Women's rights and Feminism

Women's Fightback 5 martin Thu, 02/21/2008 - 01:35

Haggling over the price of life

Submitted by Matthew on 6 December, 2017 - 10:30 Author: Janine Booth

The National Institute of Health and Care Excellence (NICE) has approved two new medications which will help women with advanced breast cancer.

Ribociclib and palbociclib have been welcomed as “breakthrough”medicines which can prolong life and give women more time without chemotherapy. Both are suitable for post-menopausal women with hormone-receptor-positive (HR+/HER2-) breast cancer which is locally advanced or is spreading. Both are taken as a daily tablet, and are used in conjunction with an aromatase inhibitor such as Letrozole.